Novartis AG will license a messenger RNA-based autoimmune therapy from China’s Abogen Biosciences in a deal worth as much as $7.8 billion.

Oct 2, 2026 - 03:00
 0  0

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0